Cellares, the first Integrated Development and Manufacturing Organization (IDMO), proudly announces that its Cell Shuttle™ ...

Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and ...

ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy ...

Scoop ...Haun Ventures, the crypto venture giant that raised $1.5 billion across two funds back near the height of the last ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

Despite scoring a historic FDA approval last year, Adaptimmune Therapeutics is expressing concerns about its own longevity, ...

With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...

Cellares’ Cell Shuttle performed all unit operations in an automated manner, including cell isolation, enrichment, gene ...

Cellares' forward momentum continues, as the company announced April 1, 2025, a notable milestone for its Cell Shuttle.

Q4 2024 Earnings Call Transcript March 31, 2025 Brainstorm Cell Therapeutics Inc. reports earnings inline with expectations.

Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen ...